Real-world data on the use of cannabidiol in patients with Lennox-Gastaut Syndrome or Dravet Syndrome in the UK early access programme

被引：0
|
作者：
Saravanai-Prabu, S. [1 ]
Eltze, C. [2 ]
Alshehhi, S. [2 ]
Al Ghfeli, A. [2 ]
Vyas, K. [1 ]
Gusto, G. [3 ]
Khachatryan, A. [4 ]
Martinez, M. [5 ]
Desurkar, A. [6 ]
机构：
[1] Jazz Pharmaceut Inc, London, England
[2] Great Ormond St Hosp Sick Children, London, England
[3] Certara, Paris, France
[4] Certara, London, England
[5] Certara, Madrid, Spain
[6] Sheffield Childrens NHS Fdn Trust, Sheffield, England
来源：
EPILEPSIA | 2023年 / 64卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
1486
引用
收藏
页码：517 / 517
页数：1
相关论文
共 50 条
  • [1] The use of cannabidiol in patients with Lennox-Gastaut syndrome and Dravet syndrome in the UK Early Access Program: A retrospective chart review study
    Eltze, Christin
    Alshehhi, Shaikha
    Al Ghfeli, Aisha
    Vyas, Kishan
    Saravanai-Prabu, Seeta
    Gusto, Gaelle
    Khachatryan, Artak
    Martinez, Marta
    Desurkar, Archana
    EPILEPSY & BEHAVIOR REPORTS, 2025, 29
  • [2] Seizure-related outcomes with real-world use of cannabidiol in Lennox-Gastaut syndrome and Dravet syndrome: BECOME, a caregiver survey
    Le, N. M. D.
    Dixon-Salazar, T.
    Berg, A.
    Danese, S. R.
    Perry, M. S.
    Meskis, M. A.
    EPILEPSIA, 2022, 63 : 118 - 119
  • [3] Cannabidiol for Treating Lennox-Gastaut Syndrome and Dravet Syndrome in Korea
    Koo, Chung Mo
    Kim, Se Hee
    Lee, Joon Soo
    Park, Byung Joo
    Lee, Hae Kook
    Kim, Heung Dong
    Kang, Hoon Chul
    JOURNAL OF KOREAN MEDICAL SCIENCE, 2020, 35 (50)
  • [4] Caregiver-reported outcomes with real-world use of cannabidiol in Lennox-Gastaut syndrome and Dravet syndrome from the BECOME survey
    Berg, Anne T.
    Dixon-Salazar, Tracy
    Meskis, Mary Anne
    Danese, Sherry R.
    Le, Ngoc Minh D.
    Perry, M. Scott
    EPILEPSY RESEARCH, 2024, 200
  • [5] Non-seizure related outcomes with real-world use of cannabidiol in Lennox-Gastaut syndrome and Dravet syndrome: BECOME, a caregiver survey
    Dixon-Salazar, T.
    Berg, A.
    Perry, M. S.
    Meskis, M. A.
    Danese, S. R.
    Le, N. M. D.
    EPILEPSIA, 2022, 63 : 118 - 118
  • [6] New therapeutic approach in Dravet syndrome and Lennox-Gastaut syndrome with cannabidiol
    Villanueva, V.
    Carreno-Martinez, M.
    Gil Nagel-Rein, A.
    Lopez-Gonzalez, F. J.
    REVISTA DE NEUROLOGIA, 2021, 72 : S1 - S10
  • [7] Practical use of pharmaceutically purified oral cannabidiol in Dravet syndrome and Lennox-Gastaut syndrome
    Lattanzi, Simona
    Zaccara, Gaetano
    Russo, Emilio
    La Neve, Angela
    Lodi, Monica Anna Maria
    Striano, Pasquale
    EXPERT REVIEW OF NEUROTHERAPEUTICS, 2021, 21 (01) : 99 - 110
  • [8] Real-world evidence on the use of cannabidiol for the treatment of drug resistant epilepsy not related to Lennox-Gastaut syndrome, Dravet syndrome or Tuberous Sclerosis Complex
    Espinosa-Jovel, Camilo
    Riveros, Sandra
    Bolanos-Almeida, Carlos
    Salazar, Mateo Ramirez
    Inga, Leidy Ceballos
    Guio, Laura
    SEIZURE-EUROPEAN JOURNAL OF EPILEPSY, 2023, 112 : 72 - 76
  • [9] Cannabidiol in the Lennox-Gastaut Syndrome
    Feng, Linda
    Hoyland, Lisa
    Poulton, Alison
    NEW ENGLAND JOURNAL OF MEDICINE, 2018, 379 (08): : 794 - 794
  • [10] Use of cannabidiol in the treatment of epilepsy: Lennox-Gastaut syndrome, Dravet syndrome, and tuberous sclerosis complex
    Silvinato, Antonio
    Floriano, Idevaldo
    Bernardo, Wanderley Marques
    REVISTA DA ASSOCIACAO MEDICA BRASILEIRA, 2022, 68 (10): : 1345 - 1357
12345